A made-in-Canada vaccine to protect against COVID-19 is now in human clinical trials in Toronto. Providence Therapeutics CEO Brad Sorenson says they’ve purchased a site in Calgary to mass produce the vaccine. He spoke with Rob Brown about the
This post was originally published on this site